A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
The goal of this research agenda is to improve the quality of end-of-life care by explicitly identifying values that will guide the decision-making process, with a particular emphasis on the role of ethnic, racial and cultural factors.
Checked against the public recordLast updated Dec 14, 2015 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- VA Office of Research and Development
- Interventions being studied
- Other: Values Inventory (VI)
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Eligible patients will be at risk for 6-12 month mortality and have one of the following diagnoses: * congestive heart failure, with ejection fraction of \<25%; * severe chronic obstructive pulmonary disease/emphysema with dependence on oxygen; * chronic liver disease with cirrhosis and ascites; * colon carcinoma with liver metastases; or * non-small cell cancer of the lung, stage III or IV * chronic kidney disease on renal replacement therapy, with previous hospitalization * All participants will be age 55 years or older and will be recruited through the clinics at the Houston VAMC. Exclusion Criteria: * Patients with dementia * Patients less than 55 years old
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Michael E DeBakey VA Medical CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 14, 2015. Always confirm current availability with the study team.